PLXP
PLx Pharma Inc.
$0.04
Earnings Summary
Revenue | $0.39Mn |
Net Profits | $-8.5Mn |
Net Profit Margins | -2201.3% |
Highlights
PLx Pharma Inc.’s revenue fell -94.17% since last year same period to $0.39Mn in the Q3 2022. On a quarterly growth basis, PLx Pharma Inc. has generated -20.08% fall in its revenue since last 3-months.
PLx Pharma Inc.’s net profit jumped 60.74% since last year same period to $-8.5Mn in the Q3 2022. On a quarterly growth basis, PLx Pharma Inc. has generated 28.34% jump in its net profits since last 3-months.
PLx Pharma Inc.’s net profit margin fell -572.93% since last year same period to -2201.3% in the Q3 2022. On a quarterly growth basis, PLx Pharma Inc. has generated 10.34% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the PLx Pharma Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.28 |
EPS Estimate Current Year | -0.28 |
Highlights
PLx Pharma Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.28 - a 36.36% jump from last quarter’s estimates.
PLx Pharma Inc.’s earning per share (EPS) estimates for the current year stand at -0.28.
Key Ratios
Key ratios of the PLx Pharma Inc. post its Q3 2022 earnings
Earning Per Share (EPS) | -0.3 |
Highlights
PLx Pharma Inc.’s earning per share (EPS) jumped 62.5% since last year same period to -0.3 in the Q3 2022. This indicates that the PLx Pharma Inc. has generated 62.5% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-11-10 | -0.44 | -0.3 | 31.82% |
2022-05-13 | -0.72 | -0.39 | 45.83% |
2022-08-12 | -0.56 | -0.43 | 23.21% |
₹0 US Stocks a/c Opening Fee